绝经后妇女使用激素补充疗法(HRT)可降低骨质疏松与心血管病的发病率及死亡率。HRT的另一优点为可提高生活质量,经治疗的乳癌妇女亦存在同一优点,然而传统的观念认为其可使已存在的乳癌加重,从而影响乳癌妇女使用HRT。目前尚无前瞻性研究证实HRT对乳癌妇女的潜在危险性,因此HRT的已知有益性超过其未明确的危险性。作者主张告诉患者有关HRT的危险性,并且对愿意使用该疗法的患者给予治疗。 Postmenopausal women use hormone replacement therapy (HRT) to reduce the incidence and mortality of osteoporosis and cardiovascular disease. Another advantage of HRT is that it can improve the quality of life. The treated breast cancer women also have the same advantages. However, the traditional concept is that it can make the existing breast cancer worse and thus affect the use of HRT in breast cancer women. There is no prospective study to confirm the potential risk of HRT to breast cancer women. Therefore, the known beneficialness of HRT exceeds its undefined risk. The authors advocate telling patients about the risk of HRT, and treating patients who are willing to use the therapy.